Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-09, with 28 holding rows worth $439,356,000.

Accession
0001567619-20-018895
Filed
2020-11-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 28 entries on the cover page, a total value of $439,356,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $439,356,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Medtronic PlcG5960L103COM320,121$33,267,000thousands by filing date
Merck & Co.,Inc.58933Y105COM393,374$32,630,000thousands by filing date
Bristol-Myers Squibb Company110122108COM541,194$32,629,000thousands by filing date
Gilead Sciences,Inc.375558103COM477,094$30,148,000thousands by filing date
INCYTE CORP COM45337C102Stock284,904$25,567,000thousands by filing date
REVVITY INC714046109COM202,707$25,442,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM215,068$24,610,000thousands by filing date
Boston Scientific Corporation101137107COM555,002$21,207,000thousands by filing date
BIOGEN INC COM09062X103Stock67,343$19,104,000thousands by filing date
Abbott Laboratories002824100COM170,219$18,525,000thousands by filing date
Elevance Health, Inc.036752103COM67,802$18,211,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock169,734$17,133,000thousands by filing date
BRUKER CORP116794108COM386,961$15,382,000thousands by filing date
CVS Health Corporation126650100COM251,781$14,704,000thousands by filing date
NUVASIVE INC670704105COM289,436$14,058,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM285,281$13,394,000thousands by filing date
BIO RAD LABS INC090572207CL A25,452$13,119,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW60,263$11,346,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock236,342$11,214,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock216,780$9,952,000thousands by filing date
Johnson & Johnson478160104COM57,116$8,503,000thousands by filing date
HCA Healthcare Inc40412C101COM65,956$8,223,000thousands by filing date
LIVANOVA PLCG5509L101SHS143,361$6,481,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock200,111$5,589,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,365,286$3,277,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock19,491$2,838,000thousands by filing date
CERNER CORP156782104COM26,122$1,888,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM156,969$915,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-20-018895this filing2020-11-09acceptance time not in the bulk data set